SubHero Banner
Text

Bomyntra® (denosumab-bnht) – New biosimilar approval

March 25, 2025 - Fresenius Kabi announced the FDA approval of Bomyntra (denosumab-bnht), biosimilar to Amgen’s Xgeva® (denosumab).

Download PDF

Text